date,title,source
Nov-01-18,"Magenta Therapeutics Announces Acceptance of Nine Abstracts Covering Clinical and Preclinical Data at ASH, Representing Progress across the Portfolio of Conditioning, Stem Cell Mobilization and Expansion Programs",Business Wire
Nov-08-18,Magenta Therapeutics Reports Recent Operational Progress and Third Quarter 2018 Financial Results,Business Wire
Nov-19-18,Magenta Therapeutics Appoints Jason Ryan as Chief Operating and Financial Officer,Business Wire
Nov-26-18,Magenta Therapeutics to Host Webcast of Investor and Analyst Event During ASH,Business Wire
Jan-02-19,"Magenta Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019",Business Wire
Feb-07-19,Magenta Therapeutics to Present at Guggenheim Healthcare Investor Conference,Business Wire
Feb-21-19,"Magenta Therapeutics Presents Preclinical Data on MGTA-145, First-Line Stem Cell Mobilization Product Candidate for Autologous and Allogeneic Bone Marrow Transplant",Business Wire
